Acquirer
Merck & Co., Inc.
Merck & Co., Inc. appears as the named buyer in 12 recorded transactions between 2014 and 2024, most often in healthcare & life sciences, software & internet and industrials & manufacturing. 1 of those was bought from a private equity seller, which makes this a buyer that funds in the sector actually exit to.
Record
What Merck & Co., Inc. has bought
Every recorded transaction where Merck & Co., Inc. is the named buyer. Most private deals never disclose a consideration, so a dash is the normal case rather than a gap in the record.
| Target | Sector | Sold by | Date | Consideration |
|---|---|---|---|---|
| CN201 | Healthcare & Life Sciences | Curon Biopharmaceutical | 2024-08-09 | $700m |
| UnitySC | Software & Internet | — | 2024-07-18 | $175m |
| Harpoon Therapeutics | Healthcare & Life Sciences | — | 2024-01-08 | $680m |
| Caraway Therapeutics | Healthcare & Life Sciences | — | 2023-11-21 | $610m |
| Exelead | Healthcare & Life Sciences | — | 2022-01-06 | $780m |
| OncoImmune | Healthcare & Life Sciences | — | 2020-11-23 | $425m |
| Virbac SA - SENTINEL U.S. Rights | Healthcare & Life Sciences | Virbac | 2020-05-13 | $400m |
| Intermolecular | Industrials & Manufacturing | — | 2019-05-06 | $62m |
| Immune Design Corp. | Healthcare & Life Sciences | — | 2019-02-21 | $300m |
| Viralytics Ltd. | Healthcare & Life Sciences | — | 2018-02-21 | $357m |
| Afferent Pharmaceuticals | Healthcare & Life Sciences | — | 2016-06-09 | $500m |
| OncoEthix SA | Healthcare & Life Sciences | Edmond de Rothschild Private Equity PE | 2014-12-18 | $110m |
Compiled from an archive of 10,204 recorded transactions. This is a record of deals that were reported, not a complete history of what this company has bought, and nothing here is represented as being for sale.
Also buying
Comparable buyers
Other companies acquiring in healthcare & life sciences.
For owners
Own a healthcare & life sciences business?
The investors on this page acquire companies like yours. A confidential valuation costs nothing, commits you to nothing, and nobody is told you asked.
Request a confidential valuationFor investors
Are you an investor?
Register your mandate and we will send matching opportunities as they arise.
Register a mandateTargeted buyer search
Which hundred of these would actually buy your business?
A researched shortlist with a verified deal-team contact for each, and the reason it is on the list. Fixed fee, from $1,450 - or we make the approach for you and hand you the conversations.